Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:ImmunityBio,_Inc.
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
immunotherapy
natural killer cell therapies |
| gptkbp:formerName |
Conkwest, Inc.
|
| gptkbp:foundedBy |
gptkb:Patrick_Soon-Shiong
|
| gptkbp:foundedYear |
2002
|
| gptkbp:headquartersLocation |
gptkb:Culver_City,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NantKwest, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:keyPerson |
gptkb:Patrick_Soon-Shiong
|
| gptkbp:tradedOn |
gptkb:NASDAQ:NK
|
| gptkbp:bfsParent |
gptkb:NASDAQ:NK
|
| gptkbp:bfsLayer |
7
|